Depomed reported $15.36M in EBITDA for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aerie Pharmaceuticals AERI:US $ -32.04M 85.4M
Ani Pharmaceuticals ANIP:US $ -4.64M 2.68M
Aurora Cannabis Inc ACB:CN -88561000 17.03M
Cara Therapeutics CARA:US $ -27848000 5.61M
Daiichi Sankyo 4568:JP Y -35701M 88958M
Ironwood Pharmaceuticals IRWD:US $ 58.2M 1.25M
Johnson & Johnson JNJ:US $ 9309M 1549M
Knight Therapeutics Inc GUD:CN C$ 13.06M 7.1M
Merk MRK:US $ 6179M 492M
Nektar Therapeutics NKTR:US $ -111.36M 1.88M
Pfizer PFE:US $ 11182M 4046M
Teva Pharmaceutical TEVA:IT 1.11B 176M